Leonteq Securities AG’s Mirum Pharmaceuticals MIRM Stock Holding History

Leonteq Securities AG’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.6K	Buy	+304	New	+$30.5K	﹤0.01%	869
2024 Q4	–	Sell	-5,000	Closed	-$195K	–	1305
2024 Q3	$195K	Hold	5,000	–	–	0.01%	494
2024 Q2	$171K	Hold	5,000	–	–	0.01%	516
2024 Q1	$126K	Hold	5,000	–	–	0.01%	599
2023 Q4	$148K	Hold	5,000	–	–	0.01%	562
2023 Q3	$158K	Hold	5,000	–	–	0.01%	573
2023 Q2	$129K	Hold	5,000	–	–	0.01%	622
2023 Q1	$120K	Hold	5,000	–	–	0.01%	622
2022 Q4	$97.5K	Buy	+5,000	New	+$98.8K	﹤0.01%	673

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Leonteq Securities AG's MIRM Position: Q2 2026 in Review

Leonteq Securities AG opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 304 shares worth $35.6K. The stake represents ﹤0.01% of the portfolio and ranks #869 among its holdings. This is a return to the name: Leonteq Securities AG previously reported a position in MIRM as recently as Q3 2024.

Leonteq Securities AG first reported a position in MIRM in Q4 2022 and has held it in 9 quarters since. The position peaked at $195K in Q3 2024. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Leonteq Securities AG held 304 shares of Mirum Pharmaceuticals worth $35.6K as of Q2 2026.
Mirum Pharmaceuticals was a new Leonteq Securities AG position in Q2 2026.
Mirum Pharmaceuticals made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #869 holding.
Leonteq Securities AG first reported a position in Mirum Pharmaceuticals in Q4 2022 and has held it in 9 quarters since.
Leonteq Securities AG's Mirum Pharmaceuticals position peaked at $195K in Q3 2024.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.